糖尿病性心肌病
内科学
心功能曲线
医学
脂质代谢
内分泌学
心肌病
糖尿病
功能(生物学)
新陈代谢
心肌肥大
心脏功能不全
动物模型
脂代谢紊乱
脂质积聚
能量代谢
胰岛素
心肌
胰岛素抵抗
心脏纤维化
心脏病学
血脂谱
碳水化合物代谢
链脲佐菌素
作者
Zeyu Zhou,Xiaotong Yang,Wanyu Li,Xiaoli Liu,Xiaojian Wang,Shaojun Wu,Rong Gu
摘要
Diabetic cardiomyopathy (DCM) is one of the most serious complications of diabetes. N-lactoyl-phenylalanine (Lac-Phe), an endogenous metabolite, can promote weight loss and improve glucose homeostasis. This study sought to investigate the therapeutic effect of Lac-Phe on DCM and further explore the underlying mechanism. Type 2 diabetic mice with DCM were treated with Lac-Phe. Lac-Phe enhanced cardiac contractile function, ameliorated pathological remodeling, and reduced lipid accumulation in the heart. In vitro, the effects of Lac-Phe were investigated in H9c2 cells stimulated with high glucose and palmitic acid. Lac-Phe reduced lipid accumulation by decreasing cholesterol synthesis in H9c2 cells. Mechanistically, Lac-Phe promoted the phosphorylation and activation of adenosine monophosphate-activated protein kinase alpha 1 (AMPKα1). Subsequently, activated AMPKα1 phosphorylated and inhibited its downstream target, 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), leading to reduced cholesterol synthesis and ultimately ameliorating lipid metabolism imbalance in H9c2 cells. These findings indicate that Lac-Phe improves lipid metabolism in H9c2 cells in DCM through the AMPKα1/HMGCR pathway, thereby enhancing cardiac contractile function and ameliorating pathological remodeling. Lac-Phe may represent a potential therapeutic approach for diabetic cardiomyopathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI